Mengis Capital Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Mengis Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 05, 2018	SELL	$351.14 - $408.51 $735,638 - $855,828	-2,095 Closed	0 $0
Q2 2018 Jul 24, 2018	SELL	$284.6 - $344.99 $11,384 - $13,799	-40 Reduced 1.87%	2,095 $722,000
Q1 2018 Apr 27, 2018	SELL	$315.82 - $393.78 $9,474 - $11,813	-30 Reduced 1.39%	2,135 $735,000
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $28,690 - $37,596	-80 Reduced 3.56%	2,165 $813,000
Q3 2017 Nov 06, 2017	BUY	$431.38 - $504.0 $968,448 - $1.13 Million	2,245	2,245 $1 Million

1,480

85.7M

908K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $90.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mengis Capital Management, Inc. with notifications on news.